COSCIENS Biopharma
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $3,322 | $1,871 | $2,337 | $2,052 |
Gross Profit | 2,049 | 957 | 819 | 901 |
Net Income | -6,731 | -5,755 | -1,422 | -1,398 |
Net Change In Cash | 3,322 | 1,871 | 2,337 | 2,052 |
Free Cash Flow | -3,308 | -7,910 | -1,546 | -3,999 |
Cash | 16,393 | 19,998 | 27,804 | 3,513 |
Basic Shares | 3,123 | 3,121 | 3,061 | 1,847 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $9,587 | $7,143 | $14,572 | $13,486 |
Gross Profit | 4,729 | 2,938 | 8,556 | 8,209 |
Net Income | -15,309 | -3,485 | 3,448 | 2,639 |
Net Change In Cash | 9,587 | 7,143 | 14,572 | 13,486 |
Free Cash Flow | -15,729 | -3,304 | 6,247 | 2,801 |
Cash | 16,393 | 8,843 | 13,810 | 7,780 |
Basic Shares | 3,123 | 78,293 | 78,233 | 77,685 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$2.14 |
2024-09-30 | -$1.85 |
2024-06-30 | -$0.64 |
2024-03-31 | -$18.95 |
